Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Multiple Myeloma: About this Condition

Multiple myeloma is a cancer of cells found in the body’s bone marrow. These cells, called plasma cells, normally protect us from infections.

When plasma cells become cancerous, they can no longer fulfill their normal job. They also tend to crowd out space in the bone marrow needed for other cells. As a result, there may be a loss of red blood cells, causing anemia, and fewer white blood cells to fight infections.

The plasma cells can also travel to other parts of the body including the bone, making the bone more prone to fracture, and affecting the kidneys.

At Stanford Health Care, we’re here to help you through the diagnosis and treatment of your condition.

Clinical Trials for Multiple Myeloma

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.